Text · Adopted text
Discharge 2022: Circular Bio-based Europe Joint Undertaking
Document TA-9-2024-0273 · P9_TA(2024)0273 · PE753.488
- Kind
- Adopted text TA-9-2024-0273
- Date
- 11 April 2024
- Dossier
- 2023-2174
More facts (2)
- Formats
- Official page PDF Word
- Subject matter
- BUDG
In short
A summary of the text written by AI; ¶ opens the paragraph it rests on.
AI: In short Written by AI from the official text — check the source · deepseek-flash · 25 Sept 2026
Parliament grants the Executive Director of the Circular Bio-based Europe Joint Undertaking (CBE JU) discharge for the 2022 budget and approves the closure of its 2022 accounts. In its resolution, Parliament notes the Court of Auditors' finding that the 2022 accounts are fairly presented and the underlying transactions legal and regular. It notes low budget execution, a surplus of unused BBI JU appropriations, and that private members will not meet their Horizon 2020 contribution targets. It calls on the CBE JU to close the gap between recognised cash and in-kind contributions, set a time-scheduled action plan for old projects, and monitor private members' contributions annually.
Key points
- Parliament grants discharge to the Executive Director of the CBE JU for the implementation of its 2022 budget.
- Parliament approves the closure of the CBE JU's accounts for the financial year 2022.
- Parliament notes that the 2022 annual accounts present fairly the CBE JU's financial position and that the underlying transactions are legal and regular.
- Parliament notes that the total available 2022 budget was EUR 264,2 million in commitment appropriations and EUR 80,3 million in payment appropriations, with execution of 47 % and 65 % respectively.
- Parliament notes a surplus of unused BBI JU appropriations at end-2022: EUR 1,1 million in administrative commitment appropriations, EUR 1,5 million in administrative payment appropriations and EUR 25,2 million in operational payment appropriations.
- Parliament notes that for Horizon 2020 private members will not achieve their indicative contribution target for operational activities by the end of the programme.
- Parliament notes that the CBE JU fully committed the maximum Union operational contribution of EUR 815,8 million for Horizon 2020 signed grant agreements, of which around EUR 94 million remains to be paid.
- Parliament notes that private members had legally committed EUR 258,4 million, or 54 % of the indicative target of EUR 475,3 million, for operational activities.
- Parliament notes that the CBE JU revised upwards to EUR 2 235,5 million its target for private members' in-kind contributions to additional activities, against an overall target of EUR 2 730 million.
- Parliament calls on the CBE JU to address the gap between recognised cash and in-kind contributions by providing information on members' legal commitments at year end.
- Parliament agrees with the Court that the CBE JU should establish a time-scheduled action plan for finalising projects under previous Multiannual Financial Frameworks and monitor private members' contributions annually.
- Parliament notes that for Horizon 2020 expenditure the JU reported a representative error rate of 1,9 % and a residual error rate of 1,2 %.
Who is affected
- The Circular Bio-based Europe Joint Undertaking and its Executive Director, who receives discharge and must address Parliament's observations.
- Private members of the CBE JU, including the Bio-based Industries Consortium, whose contribution targets are not being met.
- The Commission and the Court of Auditors, which receive the decision and resolution.
Figures and deadlines
- EUR 264,2 million in commitment appropriations and EUR 80,3 million in payment appropriations: total available 2022 budget.
- EUR 125 million (47 % execution) and EUR 52 million (65 % execution): budget implementation for commitment and payment appropriations.
- EUR 1,1 million in administrative commitment appropriations, EUR 1,5 million in administrative payment appropriations and EUR 25,2 million in operational payment appropriations: surplus of BBI JU unused appropriations at end-2022.
- EUR 815,8 million: maximum Union operational contribution for Horizon 2020 signed grant agreements.
- EUR 94 million (or 11,5 %): amount remaining to be paid for Horizon 2020 projects yet to be completed.
- EUR 258,4 million or 54 % of the indicative target of EUR 475,3 million: private members' legally committed contributions to operational activities.
- EUR 2 730 million: overall private members' contribution target set in the CBE JU's Founding Regulation.
- 1,9 % representative error rate and 1,2 % residual error rate: for Horizon 2020 expenditure.
Legal basis. Article 319 of the Treaty on the Functioning of the European Union
Text
The text as parsed from the official Word file. Every paragraph has a link (¶) and can be saved to a project as a passage.
1. European Parliament decision of 11 April 2024 on discharge in respect of the implementation of the budget of the Circular Bio-based Europe Joint Undertaking for the financial year 2022 (2023/2174(DEC))
–having regard to the final annual accounts of the Circular Bio-based Europe Joint Undertaking for the financial year 2022,
–having regard to the Court of Auditors’ annual report on the EU Joint Undertakings for the financial year 2022, together with the Joint Undertakings’ replies,
–having regard to the statement of assurance as to the reliability of the accounts and the legality and regularity of the underlying transactions provided by the Court of Auditors for the financial year 2022, pursuant to Article 287 of the Treaty on the Functioning of the European Union,
–having regard to the Council’s recommendation of 22 February 2024 on discharge to be given to the Joint Undertaking in respect of the implementation of the budget for the financial year 2022 (06182/2024 – C90112/2024),
–having regard to Regulation (EU, Euratom) 2018/1046 of the European Parliament and of the Council of 18 July 2018 on the financial rules applicable to the general budget of the Union, amending Regulations (EU) No 1296/2013, (EU) No 1301/2013, (EU) No 1303/2013, (EU) No 1304/2013, (EU) No 1309/2013, (EU) No 1316/2013, (EU) No 223/2014, (EU) No 283/2014, and Decision No 541/2014/EU and repealing Regulation (EU, Euratom) No 966/2012, and in particular Article 71 thereof,
–having regard to Council Regulation (EU) 2021/2085 of 19 November 2021 establishing the Joint Undertakings under Horizon Europe and repealing Regulations (EC) No 219/2007, (EU) No 557/2014, (EU) No 558/2014, (EU) No 559/2014, (EU) No 560/2014, (EU) No 561/2014 and (EU) No 642/2014, and in particular Article 26 thereof,
–having regard to Commission Delegated Regulation (EU) 2019/887 of 13 March 2019 on the model financial regulation for public-private partnership bodies referred to in Article 71 of Regulation (EU, Euratom) 2018/1046 of the European Parliament and of the Council,
–having regard to the opinions of the Committee on Regional Development and the Committee on Industry, Research and Energy,
1.Grants the Executive Director of the Circular Bio-based Europe Joint Undertaking discharge in respect of the implementation of the Joint Undertaking’s budget for the financial year 2022;
3.Instructs its President to forward this decision and the resolution forming an integral part of it to the Executive Director of the Circular Bio-based Europe Joint Undertaking, the Council, the Commission and the Court of Auditors, and to arrange for their publication in the Official Journal of the European Union (L series).
2. European Parliament decision of 11 April 2024 on the closure of the accounts of the Circular Bio-based Europe Joint Undertaking for the financial year 2022 (2023/2174(DEC))
–having regard to the final annual accounts of the Circular Bio-based Europe Joint Undertaking for the financial year 2022,
–having regard to the Court of Auditors’ annual report on the EU Joint Undertakings for the financial year 2022, together with the Joint Undertakings’ replies,
–having regard to the statement of assurance as to the reliability of the accounts and the legality and regularity of the underlying transactions provided by the Court of Auditors for the financial year 2022, pursuant to Article 287 of the Treaty on the Functioning of the European Union,
–having regard to the Council’s recommendation of 22 February 2024 on discharge to be given to the Joint Undertaking in respect of the implementation of the budget for the financial year 2022 (06182/2024 – C90112/2024),
–having regard to Regulation (EU, Euratom) 2018/1046 of the European Parliament and of the Council of 18 July 2018 on the financial rules applicable to the general budget of the Union, amending Regulations (EU) No 1296/2013, (EU) No 1301/2013, (EU) No 1303/2013, (EU) No 1304/2013, (EU) No 1309/2013, (EU) No 1316/2013, (EU) No 223/2014, (EU) No 283/2014, and Decision No 541/2014/EU and repealing Regulation (EU, Euratom) No 966/2012, and in particular Article 71 thereof,
–having regard to Council Regulation (EU) 2021/2085 of 19 November 2021 establishing the Joint Undertakings under Horizon Europe and repealing Regulations (EC) No 219/2007, (EU) No 557/2014, (EU) No 558/2014, (EU) No 559/2014, (EU) No 560/2014, (EU) No 561/2014 and (EU) No 642/2014, and in particular Article 26 thereof,
–having regard to Commission Delegated Regulation (EU) 2019/887 of 13 March 2019 on the model financial regulation for public-private partnership bodies referred to in Article 71 of Regulation (EU, Euratom) 2018/1046 of the European Parliament and of the Council,
1.Approves the closure of the accounts of the Circular Bio-based Europe Joint Undertaking for the financial year 2022;
2.Instructs its President to forward this decision to the Executive Director of the Circular Bio-based Europe Joint Undertaking, the Council, the Commission and the Court of Auditors, and to arrange for its publication in the Official Journal of the European Union (L series).
3. European Parliament resolution of 11 April 2024 with observations forming an integral part of the decision on discharge in respect of the implementation of the budget of the Circular Bio-based Europe Joint Undertaking for the financial year 2022 (2023/2174(DEC))
–having regard to its decision on discharge in respect of the implementation of the budget of the Circular Bio-based Europe Joint Undertaking for the financial year 2022,
–having regard to the opinions of the Committee on Regional Development and the Committee on Industry, Research and Energy,
A.whereas the Circular Bio-based Europe Joint Undertaking (the ‘CBE JU’), located in Brussels, was set up in November 2021 under the Horizon Europe programme for the period ending on 31 December 2031; whereas the CBE JU replaced and succeeded the Bio-based Industries Joint Undertaking (the ‘BBI Joint Undertaking’) that was set up in May 2014 under the Horizon 2020 programme for a period until 31 December 2024;
B.whereas the CBE JU is a public-private partnership focusing on research and innovation for a sustainable and competitive circular bio-based industries sector; whereas its founding members are the Union, represented by the Commission, and industrial partners represented by the Bio-based Industries Consortium;
C.whereas, to increase transparency, the CBE JU should disclose in its annual accounts, relevant information regarding members’ contributions at programme level; whereas, for each programme under which they operate, the CBE JU should present per member category up to the year-end, all relevant information including the legal contribution targets set for the relevant programme, the volume of contributions received, and the volume of legal commitments; whereas the CBE JU should continue to improve transparency;
1.Notes that, according to the report of the Court of Auditor’s (the ‘Court’) on the annual accounts of the CBE JU for the financial year 2022 (the ‘Court’s report’), the annual accounts present fairly, in all material respects, the financial position of the CBE JU on 31 December 2022, the results of its operations, its cash flows, and the changes in net assets for the year then ended, in accordance with its Financial Regulation and with accounting rules adopted by the Commission’s accounting officer; notes, furthermore, from the Court’s report that the underlying transactions to the accounts are, in all material respects, legal and regular;
3.Notes that the changes in the size of the CBE JU’s budget largely depend on the implementation phase of the multiannual research and innovation programmes, which it is implementing;
4.Notes that, in 2022, the CBE JU started with the implementation of the Horizon Europe programme and, as a consequence, the 2022 budget includes the commitment budget for the first Horizon Europe calls planned for 2021 and 2022;
5.Notes, from the CBE JU’s Consolidated Annual Activity Report 2022, that the total available budget for 2022 was EUR 264,2 million in commitment appropriations and EUR 80,3 million in payment appropriations; notes, as regards budget implementation/execution, that, for commitment appropriations, it was EUR 125 million (47 % execution) and for payment appropriations EUR 52 million (65 % execution);
6.Notes, that the Governing Board adopted the 2022 budget for the CBE JU in two stages - on 16 December 2021, the budget for the BBI JU legacy part was voted for a total of EUR 6 million in commitment appropriations (CA) and EUR 85,6 million in payment appropriations (PA);
7.Notes, moreover, that no grants were signed under the mandate of the CBE JU and that 142 grants were signed under the mandate of BBI JU for a total value of EUR 822 million;
8.Notes that, on 31 May 2022, with a budgetary amendment to add the 2022 (fresh) budget for the CBE JU, comprising EUR 254,9 million in CA and EUR 1,7 million in PA; notes that the amendment also included a reduction of EUR 11,2 million to the BBI JU operational PA reactivations, deemed at that stage to be surplus to needs (so total CA budget amendment was -EUR 9,6 million (minus);
9.Notes that, on 28 November 2022, another amendment to the budget provided an extra EUR 1 million PA for the CBE JU expert evaluators under Title 3, and in order to reflect at accounting level the approach taken by the European Commission for the treatment of PA for expert evaluators in the calls;
10.Notes that the original BBI JU budget included a relatively large surplus of unused budget from prior years (2019, 2020 and 2021): on the administrative side, EUR 1,1 million in CA and EUR 1,6 million in PA and on the operational side EUR 40 million in PA;
11.Notes that these reactivated appropriations were consumed in line with CBE JU Financial Rules Article 6(5), and reached 69 % consumption on the admin CA side, 88 % on the admin PA side and 100 % on the operational PA side by year end; notes that the main reason for the lower execution in the administrative budget is that a large amount of appropriations were kept available on the Title 2 communications budget lines until the very end of the year, in view of committing the contract for the Stakeholder Forum event taking place in 2023;
12.Notes, however, that, according to the CBE JU, it was not possible to manage this, and the contract was eventually signed in mid-January 2023 and the appropriations reactivated in the budgets of 2023 and 2024;
13.Notes that, at the end of 2022, there was a total surplus of BBI JU unused appropriations of EUR 1,1 million in administrative CA and EUR 1,5 million in administrative PA and that in operational PA there was EUR 25,2 million;
14.Notes that on the CBE JU side there were no significant reactivated appropriations as no budget had been requested for prior 2021; notes, however, that a budget originally foreseen for the CBE JU on the side of the Commission (including a 2021 call which never took place) had been committed by DG RTD, the CBE JU had to assume in its 2022 administrative and operational budget the foreseen CBE JU CA and PA for both years 2021 and 2022;
15.Notes, moreover, that, on the administrative side, the execution of the BBI JU legacy budget will be prioritised until end of 2024, as almost none of the CBE JU admin budget was executed in 2022; notes that this reduces the overall budget execution, but for this exercise the implementation rates of the BBI JU - only admin budget will also be given for a realistic comparison;
16.Notes, from the Court’s report, that in the JU’s 2022 annual accounts, the amounts of contributions recognised per member category (the Union and private members) differ significantly from each other; understands that this is because Union cash contributions are validated and recognised when paid to the CBE JU at the beginning of the project implementation, but members’ in-kind contributions are only recognised after validation of the costs incurred and declared for project implementation;
17.Calls on the CBE JU to address the gap between the recognised amount of cash contributions on the one hand and in-kind contributions on the other hand by providing information on the JU members’ legal commitments at year end, in terms of signed grant agreements and contracts; welcomes the commitment of the CBE JU to address the issue in the following year's annual accounts;
18.Notes that the validated private members’ in-kind contributions for operational activities remained low at EUR 65,9 million because the CBE JU only certifies the contributions when the final payments for the Horizon 2020 projects are made, and the certificates of financial statement are due;
19.Notes with concern that for Horizon 2020 private members will not achieve their indicative contribution target for operational activities at the end of the programme implementation;
20.Notes the risks in relation to programme implementation for the CBE JU in the event that private members will not achieve the minimum contributions targets by the end of the Horizon 2020 programme;
21.Notes that, regarding the CBE JU’s achievements for the Horizon 2020, the CBE JU, at the end of 2022, had fully committed the maximum Union operational contribution of EUR 815,8 million for signed grant agreements under Horizon 2020 programme; notes, in addition, that, of this committed amount, around EUR 94 million (or 11,5 %) remains to be paid in the coming years for projects yet to be completed;
22.Notes, furthermore, at the end of 2022, the private members had legally committed to provide in-kind and financial contributions to the CBE JU’s operational activities of EUR 258,4 million or 54 % of the indicative target of EUR 475,3 million set in the JU’s adopted annual working programmes; notes that, of this committed amount, the CBE JU reported EUR 154,7 million (or 32,5 % of the target) at the end of 2022;
23.Notes, moreover, that, in 2022, the JU had to cancel around EUR 8,2 million of signed projects due to the unforeseen termination of a Horizon 2020 flagship project and suspension of several other projects and, as all Horizon 2020 calls were closed at the end of 2020, the CBE JU will not achieve the indicative target for private members’ contributions to the JU’s operational activities by the end of the programme period;
24.Welcomes the fact that the CBE JU stated that it achieved the operational objectives for its Horizon 2020 calls; notes, nevertheless that the Court considers that this significant reduction in private members’ contributions presents a risk to the overall achievement of the CBE JU’s Horizon 2020 programme;
25.Notes that to ensure the achievement of the private members’ overall contribution target of EUR 2 730 million set in the CBE JU’s Founding Regulation by the end of the programme period, the JU revised upwards to EUR 2 235,5 million, its target for private members’ in-kind contribution to additional activities; notes that at the end of 2022, the private members reported total in-kind contributions to additional activities of EUR 1 797,9 million or 73,8 % of the new target, but for EUR 658 million or 37 % of the reported amount, the certification process was not concluded;
26.Welcomes the fact that in order to mitigate the CBE JU’s risk of not achieving the new target for in-kind contributions to additional activities by the end of the programme, the Bio-based Industries Consortium proposed to the CBE JU’s Governing Board in November 2022, to approve further private members’ investment of EUR 416 million for additional activities in 2023;
27.Notes with concern that the Court considers that the implementation of the 2022 budget payments for Horizon 2020 activities worsened; acknowledges that this was due to the fact that beneficiaries faced rising costs and delivery problems;
28.Notes that for Horizon 2020 activities, the CBE JU received no new operational commitment appropriations, as the CBE JU had finished its last call for proposals by the end of 2020; notes that the implementation rate for the operational payment appropriations fell to 65 % (2021: 85 %), which, according to the CBE JU, was due to the rising costs and delivery problems faced by beneficiaries arising from the COVID-19 crisis and the war in Ukraine, therefore, the duration of most Horizon 2020 projects had to be prolonged and final payments postponed to 2023;
29.Agrees with the Court that the CBE JU should establish a time-scheduled action plan for finalising the implementation of projects approved under previous Multiannual Financial Frameworks (MFFs);
30.Agrees with the Court that to ensure the achievement of their private members’ contribution targets for the 2021- 2027 MFF, the CBE JU should, based on a strategic programme implementation plan, monitor the private members’ individual contribution achievements on an annual basis;
31.Notes that, in 2022, the JU implemented only 47 % of its commitment budget for projects under the first significant Horizon Europe call of EUR 120 million, it had launched earlier in the year;
32.Notes that, in 2022, the Commission and private members made cash contributions of EUR 0,8 million each to the administrative costs of the CBE JU; notes that the CBE JU did not request cash contributions for its Horizon Europe activities, as it only expected to finish the first Horizon Europe call it had launched early in 2022, in the first half of 2023;
33.Notes that, at the end of 2022, the implementation rate regarding the CBE JU’s salary payment budget (Title 1) was low at 55 % and that, according to the CBE JU, this was due to the delayed start of employment contracts of staff newly recruited in 2022;
34.Notes that, in 2022, the CBE JU continued exploiting as much as possible the existing framework contracts at the level of the European Commission; notes that when these contracts were not available to the CBE JU or they had expired, it was necessary to launch specific tender procedures, most of them for low-value contracts;
35.Notes that the CBE JU also signed specific contracts under the framework contract jointly managed with the other JUs namely for common IT services; notes, in addition, that throughout 2022, the CBE JU used Service Level Agreements (SLAs) in force with the Commission;
36.Notes from the Consolidated Annual Activity Report that 2022 was a transition year from BBI JU to the CBE JU; notes that, by the end of 2022, the CBE JU Programme Office comprised 26 members of staff (compared to 22 in 2021), almost reaching its full staff establishment plan under its new mandate; welcomes the fact that eight new colleagues have joined under the new mandate of the CBE JU;
37.Notes that, in 2022, the CBE JU confirmed gender balance in management positions with 50 % female representation;
38.Notes that the CBE JU staff managed an increasing number of ongoing projects for multiple MFF programmes simultaneously; draws attention to the fact that such a trend must not weaken the effectiveness of the CBE JU’s internal controls and their management of these funds and delay the implementation of the new programmes;
39.Notes from the Court’s observations on the management and control systems that for Horizon 2020 and Horizon Europe expenditure that the Common Audit Service of the Commission’s DG RTD is responsible for the ex post audits;
40.Notes that for Horizon 2020 expenditure (clearings and final payments), the JU reported a representative error rate of 1,9 % and a residual error rate of 1,2 %;
41.Notes that for the Horizon Europe programme, ex post audits have yet to be carried out, as the first interim payments are only expected in 2024;
42.Notes that to assess the operational payment controls of the CBE JU, the Court audited randomly sampled Horizon 2020 payments made in 2022, at the level of the final beneficiaries; notes that, for one case, the Court found and quantified a serious error resulting from over claimed personnel cost because the beneficiary changed the calculation method for the hourly rate within the financial year and included ineligible pension costs and bonuses in the costs declared;
43.Appreciates that the CBE JU developed a risk-based approach to ex post audit with the aim to reduce its error rate by better targeted sample to detect the most error-prone beneficiaries and thus, strengthening the cleaning effect of their ex post audits; this is an important positive change in ex post audit approach as the Commission internal control framework for Horizon Europe grants does not allow for establishing CBE JU specific representative samples and consequently, to calculate specific representative and residual error rates for joint undertakings;
44.Notes that the Court found that joint undertakings with a well-developed risk-based ex post audit approach have a residual error rate below the average of the joint undertakings without such an approach due to the systematic identification and audit of the riskiest beneficiaries;
45.Notes that “observations” in the CBE JU specific annual reports are in fact “not timed recommendations” by the Court; notes that ECA annually follows-up on those observations by assessing their status as “open” or “closed”;
46.Notes that the Court issued 3 observations (2020/2021) of which 2 remain open - relating to the contributions of the CBE JU’s industry and private members;
47.Notes that the CBE JU acknowledges the low level of private members’ in-kind contributions to its operational activities and that it considers that this situation can be partly explained by the openness of the CBE JU’s calls, where also non-members of BIC may apply for BBI grants without any obligation to support the CBE JU initiative with in-kind contributions; understands that the number of successful applicants from BIC decreased to its minimum for the last three calls, causing a significant decrease in in-kind contributions.
Connections
The dossier, the decisions on this text and its other versions.
No connections found for this item.
Sources & citation
Where the facts on this page come from, and how to cite it.
- Official source
- Data source
- Licensed CC BY 4.0.
- Retrieved
- 25 September 2026
Cite as
European Parliament (2024). “Discharge 2022: Circular Bio-based Europe Joint Undertaking”. Text, 11 April 2024. docId TA-9-2024-0273, reference TA9-0273/2024. EU Parl Watch Research. https://news.eu-parl.st-solutions.dev/texts/TA-9-2024-0273 (retrieved 25 September 2026). Official source: The text on the European Parliament’s website, https://www.europarl.europa.eu/doceo/document/TA-9-2024-0273_EN.html. Data: EP Open Data API: document record, https://data.europarl.europa.eu/api/v2/documents/TA-9-2024-0273 (CC BY 4.0).
BibTeX
@misc{epw-text-ta-9-2024-0273,
author = {{European Parliament}},
title = {{Discharge 2022: Circular Bio-based Europe Joint Undertaking}},
year = {2024},
date = {2024-04-11},
howpublished = {\url{https://news.eu-parl.st-solutions.dev/texts/TA-9-2024-0273}},
url = {https://news.eu-parl.st-solutions.dev/texts/TA-9-2024-0273},
urldate = {2026-09-25},
publisher = {EU Parl Watch Research},
note = {Text. docId TA-9-2024-0273, reference TA9-0273/2024. Official source: https://www.europarl.europa.eu/doceo/document/TA-9-2024-0273\_EN.html. Data: EP Open Data API: document record (CC BY 4.0)}
}